https://abvos.com/index.php/re....productive-system-pe
We analyzed the conversion price therefore the value of the immunophenotype of this main tumour while the relapse as a prognostic element for relapse-free success (RFS), progression-free survival (PFS) and total success (OS). RESULTS The transformation rate ended up being 34.8% for Ki-67, 20% for ER, 20% for PR, and 15.6% for HER2. When it comes to LR group, the RFS ended up being 71.9 months therefore the OS ended up being 141.6 months, without statistical variations in accordance with the
Like
Comment
Share
